NCT07725042 Analyses of Newly Diagnosed HIV Infection in Hong Kong
| NCT ID | NCT07725042 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | HIV -1 Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 720 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2029-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 720 participants in total. It began in 2024-08-01 with a primary completion date of 2029-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is: \- what is the molecular pattern and burden of HIV-1 infections over the years
Eligibility Criteria
Inclusion Criteria: * adult of age 18 or above, who are * people living with HIV, and * attending the service of an HIV specialist clinic in the public service in Hong Kong Exclusion Criteria: * travelers or visitors who are temporarily staying in Hong Kong * prisoners * patients with mental illnesses who are unable to make informed decision * patients whose HIV diagnosis was made outside Hong Kong and whose treatment have already started.
Contact & Investigator
Shui Shan S Lee, MD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT07725042 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV -1 Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07725042 currently recruiting?
Yes, NCT07725042 is actively recruiting participants. Contact the research team at sslee@cuhk.edu.hk for enrollment information.
Where is the NCT07725042 trial being conducted?
This trial is being conducted at North Point, Hong Kong.
Who is sponsoring the NCT07725042 clinical trial?
NCT07725042 is sponsored by Chinese University of Hong Kong. The principal investigator is Shui Shan S Lee, MD at Chinese University of Hong Kong. The trial plans to enroll 720 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.